Drug class
Triterpenoid saponin; licorice-derived anti-inflammatory and hepatoprotective constituent
Mechanism of action
Glycyrrhizic acid is metabolised to glycyrrhetinic acid and related metabolites. Proposed activities include modulation of HMGB1 and NF-kB signalling, anti-inflammatory and antioxidant effects, membrane stabilisation and modulation of cortisol metabolism. These actions depend on formulation and metabolism; the compound can also cause mineralocorticoid-like adverse effects through inhibition of 11β-hydroxysteroid dehydrogenase.
General use cases
- Used as an active constituent in certain licorice-derived hepatoprotective and anti-inflammatory preparations in some jurisdictions; exact indications are formulation- and jurisdiction-specific. It is not a stand-alone universal treatment for liver disease.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
